{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:30Z","timestamp":1787027010451,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Transcatheter device closure of ventricular septal defects (VSDs) offers an appealing and effective alternative to surgical repair. The Lifetech\u2122 Konar-Multifunctional Occluder (MFO) VSD occluder has gained increasing application due to its versatility and promising outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aim to evaluate our experience with the MFO device for VSD closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective analysis of clinical data from 151 patients who underwent percutaneous closure of muscular and perimembranous VSDs using the MFO device at our institution between November 2018 and September 2023. Comprehensive assessments of safety and procedural outcomes were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient's mean age was 55.4\u2009\u00b1\u200951.6 months (range, 6 months to 31 years), and the mean weight was 17.6\u2009\u00b1\u200911.9\u2005kg (range, 5\u201386). Among the patients, 94 (62.3%) had perimembranous defects, while the remaining had muscular VSDs. The mean defect diameter was 4.8\u2009\u00b1\u20091.5\u2005mm (range, 2\u201310). The retrograde approach was applied in 133 patients (88.7%). Device implantation was successful in 98.7% of patients. One procedure (0.7%) failed due to device migration, requiring surgical retrieval and VSD closure, and another patient with a significant residual shunt needed placement of an additional device in another session. The mean procedure time was 44\u2009\u00b1\u20092\u2005min, with a mean fluoroscopy time of 12.8\u2009\u00b1\u20097.7\u2005min. The mean follow-up duration was 11\u2009\u00b1\u20099.7 months (range, 6\u201335). Non-significant shunts were found in 32 patients (21.2%). Newly acquired valve regurgitation was observed in 16 patients (10.6%), including 11 patients (7.3%) with trivial-to-mild aortic regurgitation and 5 (3.3%) with moderate-to-severe tricuspid regurgitation. Electrophysiological adverse events occurred in 5 patients (3.3%), including nodal rhythm (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093, 2%), intermittent heart block (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091, 0.7%), and severe bradycardia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091, 0.7%). Vascular complications were documented in 13 patients (8.6%) including one developing chronic vascular occlusion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Percutaneous VSD closure with the MFO device is a safe, effective, and feasible procedure via both antegrade and retrograde approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1528490","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T01:32:55Z","timestamp":1743989575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Early experience with transcatheter ventricular septal defects closure with the KONAR-MF multifunctional occluder"],"prefix":"10.3389","volume":"13","author":[{"given":"Abdelrahman","family":"Elafifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susy","family":"Kotit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Shehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Deyaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ccd.26097","article-title":"Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and metaanalysis","volume":"86","author":"Saurav","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joic.12121","article-title":"A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD)","volume":"27","author":"Yang","year":"2014","journal-title":"J Interv Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4070\/kcj.2022.0336","article-title":"Percutaneous transcatheter closure of congenital ventricular septal defects","volume":"53","author":"Song","year":"2023","journal-title":"Korean Circ J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/ccd.20659","article-title":"Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry","volume":"68","author":"Holzer","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.iccl.2018.08.002","article-title":"Ventricular septal defect closure devices, techniques, and outcomes","volume":"8","author":"Morray","year":"2019","journal-title":"Interv Cardiol Clin"},{"key":"B6","first-page":"1195","article-title":"Complex ventricular septal defects. Update on percutaneous closure","volume":"57","author":"Cintez\u0103","year":"2016","journal-title":"Rom J Morphol Embryol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00246-020-02315-0","article-title":"Percutaneous device closure of congenital isolated ventricular septal defects: a single-center retrospective database study amongst 412 cases","volume":"41","author":"Walavalkar","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/0218492316645746","article-title":"Medium to long-term echo follow-up after ventricular septal defect device closure","volume":"24","author":"Rahmath","year":"2016","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1255808","DOI":"10.3389\/fcvm.2023.1255808","article-title":"Safety and efficacy of Amplatzer duct occluder II and konar-MF\u2122 VSD occluder in the closure of perimembranous ventricular septal defects in children weighing less than 10\u2005kg","volume":"10","author":"Yildiz","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.26355\/eurrev_202305_32311","article-title":"Closure of transcatheter ventricular septal defect using LifetechTM Konar-MF occluder in children weighing less than 10 kilograms: mid-term results, a tertiary single center experience","volume":"27","author":"Yildiz","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e42591","DOI":"10.7759\/cureus.42591","article-title":"Experience of percutaneous closure of ventricular septal defects in 140 patients with different duct occluders in a tertiary care rural hospital in central India","volume":"15","author":"Ghosh","year":"2023","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/eurheartj\/ehm314","article-title":"Transcatheter closure of congenital ventricular septal defects: results of the European registry","volume":"28","author":"Carminati","year":"2007","journal-title":"Eur Hear J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.hrthm.2021.11.027","article-title":"Risk factors for atrioventricular block after occlusion for perimembranous ventricular septal defect","volume":"19","author":"Lin","year":"2022","journal-title":"Hear Rhythm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ccd.27792","article-title":"Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: a multicenter experience","volume":"93","author":"Udink Ten Cate","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijcard.2017.12.011","article-title":"A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect","volume":"254","author":"Santhanam","year":"2018","journal-title":"Int J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.4244\/EIJ-D-18-00867","article-title":"First European experience of percutaneous closure of ventricular septal defects using a new CE-marked VSD occluder","volume":"15","author":"Schubert","year":"2019","journal-title":"EuroIntervention"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1215397","DOI":"10.3389\/fcvm.2023.1215397","article-title":"Comparative outcomes of two competitive devices for retrograde closure of perimembranous ventricular septal defects","volume":"10","author":"Haddad","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.3390\/jcm12196370","article-title":"Transcatheter closure of perimembranous ventricular septal defects including multifenestrated and gerbode-type defects using the lifetech konar device","volume":"12","author":"Godart","year":"2023","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2020.02.056","article-title":"Use of Lifetech\u2122 Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study","volume":"310","author":"Tanidir","year":"2020","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.24875\/RECICE.M22000277","article-title":"Percutaneous closure of ventricular septal defect with the KONAR-MF device","volume":"4","author":"\u00c1lvarez-Fuente","year":"2022","journal-title":"REC Interv Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1017\/S1047951122003547","article-title":"Early and mid-term outcomes of transcatheter closure of perimembranous ventricular septal defects using the Lifetech\u2122 Konar-MF Occluder device (MFO)","volume":"33","author":"Odemis","year":"2023","journal-title":"Cardiol Young"},{"key":"B22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S1047951121001578","article-title":"Transcatheter closure of ventricular septal defects in children less than 10\u2005kg: experience from a tertiary care referral hospital in Eastern India","volume":"32","author":"Roy","year":"2022","journal-title":"Cardiol Young"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamacardio.2022.2695","article-title":"Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial","volume":"7","author":"Van Mieghem","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E295","DOI":"10.1002\/ccd.28678","article-title":"Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience","volume":"96","author":"Haddad","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0003-4975(02)03633-0","article-title":"Anomalous origin of the left coronary artery from the pulmonary artery: collective review of surgical therapy","volume":"74","author":"Dodge-Khatami","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1046\/j1540-8175200000681.x","article-title":"Evaluation of ventricular septal defect repair using intraoperative transesophageal echocardiography: frequency and significance of residual defects in infants and children","volume":"17","author":"Yang","year":"2000","journal-title":"Echocardiography"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5334\/GH.1106","article-title":"Transcatheter closure of perimembranous ventricular septal defect using the lifetech konar-multi functional occluder: early to midterm results of the Indonesian multicenter study","volume":"17","author":"Kuswiyanto","year":"2022","journal-title":"Glob Heart"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00246-020-02456-2","article-title":"Short- and long-term outcome after interventional VSD closure: a single-center experience in pediatric and adult patients","volume":"42","author":"Bergmann","year":"2021","journal-title":"Pediatr Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ppedcard.2022.101489","article-title":"Perimembranous ventricular septal defect closure in infants with KONAR-MF occluder","volume":"65","author":"Singhi","year":"2022","journal-title":"Prog Pediatr Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fped.2019.00300","article-title":"Device closure of perimembranous ventricular septal defect: choosing between amplatzer occluders","volume":"7","author":"Haddad","year":"2019","journal-title":"Front Pediatr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/jocs.16441","article-title":"Word of caution: severe aortic valve injury linked to retrograde closure of perimembranous ventricular septal defects","volume":"37","author":"Haddad","year":"2022","journal-title":"J Card Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1017\/S1047951121002985","article-title":"Percutaneous closure of ventricular septal defect using LifeTech(TM) Konar-MF VSD occluder: initial and short-term multi-institutional results","volume":"32","author":"Sadiq","year":"2022","journal-title":"Cardiol Young"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.athoracsur.2014.01.059","article-title":"Doubly committed and juxtaarterial ventricular septal defect: outcomes of the aortic and pulmonary valves","volume":"7","author":"Devlin","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1161\/CIRCULATIONAHA.106.618124","article-title":"Ventricular septal defects","volume":"114","author":"Minette","year":"2006","journal-title":"Circulation"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1528490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T01:33:11Z","timestamp":1743989591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1528490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":34,"alternative-id":["10.3389\/fped.2025.1528490"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1528490","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"article-number":"1528490"}}